Importantly, the patient with ATRT and later MPNST had no evidence of germline alterations in SMARCB1, SMARCA4, NF1 or TP53. One patient succumbed to his secondary malignancy. This evidence concerns the gene TP53 and atypical teratoid rhabdoid tumor.